Learn how McKesson is preparing its customers for implementation.
The Drug Supply Chain Security Act (DSCSA), signed into law on Nov. 27, 2013, outlines steps to achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States. These requirements will enhance the FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.
At McKesson, we’ve closely followed the DSCSA regulation and have continued to stay heavily engaged with the FDA, the manufacturing community and our competitors to help ensure that we are compliant and that our implementation plans are executed seamlessly across all aspects of the pharmaceutical supply chain.
Click here to learn how our company is helping customers prepare for these changes brought about by the DSCSA.
How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology. How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology.
How McKesson and Health Mart are helping frontline providers deliver smarter, more compassionate care.
Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.
By teaming up with Angels for Change, we’re helping patients navigate drug shortages and access lifesaving treatments.
Health Mart pharmacies play a key role in providing accessible flu and RSV vaccination services to communities nationwide.
CoverMyMeds acquires RxLightning and FastAuth to improve medication access for patients with critical medical conditions.
Discover how McKesson Amplify is strengthening the voice of pharmacy professionals nationwide by awarding funding to every eligible state pharmacy association across all 50 states.
Top insights from the Endpoints at ASCO McKesson leadership panel
Insights and Takeaways for The Next Chapter in Specialty Medicine from Asembia AXS25
Insights from the 2025 CoverMyMeds Medication Access Report, From Barriers to Bridges
